Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REAL: Interferon Beta-1a in Early-Onset Alzheimer's Disease
NCT01075763Phase 2Completed
- Sponsor
- Merck KGaA
- Start
- Nov 2004
- Primary completion
- May 2008
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon beta-1a in Alzheimer's disease (AD), sponsored by Merck KGaA. Started Nov 2004; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01075763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01075763.